Tuesday, December 31, 2019

Alkem Labs acquires anti-nausea drug Marinol from AbbVie for $10 million

Alkem Labs acquires anti-nausea drug Marinol from AbbVie for $10 million Marionol capsules are used to treat the loss of appetite (anorexia) in AIDS patients and to treat nausea and vomiting in patients receiving chemotherapy.

from Moneycontrol Business News https://ift.tt/2rGFKLI

No comments:

Post a Comment

Paras Defence shares soar 10% as Q2 net profit jumps 50% to Rs 14 crore

Paras Defence and Space Technologies shares surged following strong September quarter results, with net profit jumping 50% and revenue climb...